Signant Health Upgrades Clinical Supplies Management Platform
GxP Inventory available in two options for varying sponsor and CRO requirements.
Signant Health has relaunched its Signant SmartSignals Supplies GxP Inventory, an upgrade to its SmartSignals Supplies software. It available as either an Essential or Enterprise option, both of which are SaaS-based, with decisions revolving around company and/or trial size.
The Essential option enables sponsors to use a pre-configured system for inventory manufacturing, management, and QA/QP release. The Enterprise option provides advanced features for larger customers with internal supply chain capabilities to meet individualized requirements, sponsor-specific terminology/labels, and additional workflow/process options.
Reference: Signant Health Extends the Power of Clinical Supply Management Software to the Small and Mid-Size Market Through Updated and Enhanced Supplies Platform, Philadelphia, PA, July 10, 2023.
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
